SLC40A1 and metabolic dysfunction-associated steatotic liver disease: This finding is consistent with previous reports in which the hepatic levels of these genes in NAFLD patients were significantly higher than in controls, suggesting that the activity of FPN1 does not coincide with the amount of FPN1 [32,51].